{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:56:24Z","timestamp":1790628984715,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106516","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:57:48Z","timestamp":1790625468000},"page":"106516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost analysis of allogeneic hematopoietic stem cell transplantation before and after the implementation of therapeutic drug monitoring"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-2703","authenticated-orcid":false,"given":"Joice","family":"Zuckermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6411-3480","authenticated-orcid":false,"given":"Ana Paula Beck","family":"da Silva Etges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-2127","authenticated-orcid":false,"given":"Bruno","family":"Mateus de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7356-119X","authenticated-orcid":false,"given":"Renata","family":"Garcia Ruschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-1003","authenticated-orcid":false,"given":"Luciana","family":"Rodrigues de Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5088-5124","authenticated-orcid":false,"given":"Lucas","family":"Bastos Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-088X","authenticated-orcid":false,"given":"Elenita","family":"Teresinha Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-6932","authenticated-orcid":false,"given":"Liane Esteves","family":"Daudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-3998","authenticated-orcid":false,"given":"Alessandra","family":"Aparecida Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4730-7988","authenticated-orcid":false,"given":"Leila Beltrami","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2026.106516_bib0001","doi-asserted-by":"crossref","unstructured":"Chen M., Liu Y., Yang X., Hong Y., Ni J. Cost analysis of childhood hematopoietic stem cell transplantation in Sichuan, China. front public health. 2023; 11:990181. doi: 10.3389\/fpubh.2023.990181. PMID: 37033079; PMCID: PMC10076710.","DOI":"10.3389\/fpubh.2023.990181"},{"key":"10.1016\/j.htct.2026.106516_bib0002","unstructured":"Center International blood & marrow transplant research. Available at:https:\/\/cibmtr.org\/CIBMTR\/Resources\/Summary-Slides-Reports. Accessed on: 20\/05\/2023"},{"issue":"7","key":"10.1016\/j.htct.2026.106516_bib0003","first-page":"366","article-title":"The cost of hematopoietic stem-cell transplantation in the United States","volume":"10","author":"Broder","year":"2017","journal-title":"Am Health Drug Benefits"},{"issue":"2","key":"10.1016\/j.htct.2026.106516_bib0004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.36401\/JQSH-19-40","article-title":"Therapeutic drug monitoring by pharmacists: does it reduce costs?","volume":"3","author":"Cardoso","year":"2020","journal-title":"Glob J Qual Saf Healthc"},{"issue":"8","key":"10.1016\/j.htct.2026.106516_bib0005","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1177\/1078155220975088","article-title":"Impact of the implementation of a pharmacist-driven immunosuppression drug monitoring protocol for hematopoietic stem cell transplant recipients","volume":"27","author":"Gawedzki","year":"2021","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"10.1016\/j.htct.2026.106516_bib0006","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/FTD.0000000000000886","article-title":"Impact of a bayesian individualization of cyclosporine dosage regimen for children undergoing allogeneic hematopoietic cell transplantation: a cost-effectiveness analysis","volume":"43","author":"Beyron","year":"2021","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.htct.2026.106516_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/cer-2018-0100","article-title":"Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany","volume":"8","author":"Mayerhoff","year":"2019","journal-title":"J Comp Eff Res"},{"issue":"2","key":"10.1016\/j.htct.2026.106516_bib0008","first-page":"166","article-title":"The use of micro-costing in an economic analysis of allogeneic HSCT in Brazil","volume":"13","author":"Vargas","year":"2021","journal-title":"J Bras Econ Sa\u00fade"},{"key":"10.1016\/j.htct.2026.106516_bib0011","unstructured":"Sociedade Brasileira de Transplante de Medula: https:\/\/sbtmo.org.br\/"},{"key":"10.1016\/j.htct.2026.106516_bib0012","unstructured":"Diretriz Metodol\u00f3gica: Estudos de microcusteio aplicados a avalia\u00e7\u00f5es econ\u00f4micas em sa\u00fade. Bras\u00edlia,2022. Acesso em: 04.03.2023"},{"issue":"3","key":"10.1016\/j.htct.2026.106516_bib0013","first-page":"226","article-title":"Cost of chronic red blood cell transfusion in the brazilian private healthcare sector from a payer perspective","volume":"12","author":"Magro","year":"2020","journal-title":"J Bras Econ Sa\u00fade"},{"issue":"9","key":"10.1016\/j.htct.2026.106516_bib0018","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3390\/pharmaceutics15092300","article-title":"A drug safety concept (I) to avoid polypharmacy risks in transplantation by individual pharmacotherapy management in therapeutic drug monitoring of immunosuppressants","volume":"15","author":"Wolf","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.htct.2026.106516_bib0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11899-018-0444-z","article-title":"Value-based care in hematopoietic cell transplantation and cellular therapy: challenges and opportunities","volume":"13","author":"Shah","year":"2018","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:57:51Z","timestamp":1790625471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2531137926002634"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106516","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost analysis of allogeneic hematopoietic stem cell transplantation before and after the implementation of therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}],"article-number":"106516"}}